Neil Carleton

910 total citations
38 papers, 586 citations indexed

About

Neil Carleton is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Neil Carleton has authored 38 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Neil Carleton's work include Colorectal Cancer Screening and Detection (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Breast Cancer Treatment Studies (5 papers). Neil Carleton is often cited by papers focused on Colorectal Cancer Screening and Detection (5 papers), Radiomics and Machine Learning in Medical Imaging (5 papers) and Breast Cancer Treatment Studies (5 papers). Neil Carleton collaborates with scholars based in United States, China and Qatar. Neil Carleton's co-authors include Steffi Oesterreich, Adrian V. Lee, Shyam Thakkar, Tullia C. Bruno, Sayali Onkar, Dario A.A. Vignali, Peter C. Lucas, Aslam Syed, Rei Ukita and Keith E. Cook and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and Gastroenterology.

In The Last Decade

Neil Carleton

33 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Neil Carleton United States 15 218 140 135 127 92 38 586
Hiromitsu Jinno Japan 16 304 1.4× 291 2.1× 391 2.9× 99 0.8× 97 1.1× 71 863
Nobuhisa Yoshikawa Japan 18 253 1.2× 145 1.0× 266 2.0× 88 0.7× 156 1.7× 91 980
Kuan‐Chou Lin Taiwan 16 120 0.6× 114 0.8× 76 0.6× 164 1.3× 156 1.7× 34 564
Michael K. Wong United States 14 382 1.8× 63 0.5× 272 2.0× 343 2.7× 66 0.7× 44 908
S. Bennis Morocco 15 198 0.9× 124 0.9× 139 1.0× 94 0.7× 144 1.6× 52 600
Con Panousis Australia 16 185 0.8× 25 0.2× 279 2.1× 54 0.4× 56 0.6× 33 989
Adrianus C. Laan Netherlands 13 145 0.7× 52 0.4× 155 1.1× 85 0.7× 69 0.8× 20 439
Sergio Vázquez‐Estévez Spain 15 233 1.1× 97 0.7× 192 1.4× 212 1.7× 158 1.7× 76 585

Countries citing papers authored by Neil Carleton

Since Specialization
Citations

This map shows the geographic impact of Neil Carleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neil Carleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neil Carleton more than expected).

Fields of papers citing papers by Neil Carleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neil Carleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neil Carleton. The network helps show where Neil Carleton may publish in the future.

Co-authorship network of co-authors of Neil Carleton

This figure shows the co-authorship network connecting the top 25 collaborators of Neil Carleton. A scholar is included among the top collaborators of Neil Carleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neil Carleton. Neil Carleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Carleton, Neil, et al.. (2025). Immuno-oncology recapitulates ontogeny: Modern cell and gene therapy for cancer. Molecular Therapy. 33(5). 2229–2237.
2.
Zou, Jian, Zheqi Li, Neil Carleton, et al.. (2024). Mutual information for detecting multi-class biomarkers when integrating multiple bulk or single-cell transcriptomic studies. Bioinformatics. 40(12). 1 indexed citations
4.
Foldi, Julia, Neil Carleton, Stewart Anderson, et al.. (2024). Long-term outcomes by lobular vs ductal histology in 4 National Surgical Adjuvant Breast and Bowel Project adjuvant breast cancer trials. JNCI Journal of the National Cancer Institute. 117(1). 163–168. 2 indexed citations
5.
Carleton, Neil, Oscar C. Marroquin, Steffi Oesterreich, et al.. (2023). Omission of surgery, primary endocrine therapy adherence, and effect of comorbidity in older women with estrogen receptor positive breast cancer. Journal of Geriatric Oncology. 15(3). 101679–101679. 1 indexed citations
6.
Oesterreich, Steffi, Adrian V. Lee, & Neil Carleton. (2023). Response to Maltoni, Puccetti, Poli, et al.. JNCI Journal of the National Cancer Institute. 115(4). 479–481. 1 indexed citations
7.
Oesterreich, Steffi, Azadeh Nasrazadani, Jian Zou, et al.. (2022). Clinicopathological Features and Outcomes Comparing Patients With Invasive Ductal and Lobular Breast Cancer. JNCI Journal of the National Cancer Institute. 114(11). 1511–1522. 31 indexed citations
8.
Onkar, Sayali, Neil Carleton, Peter C. Lucas, et al.. (2022). The Great Immune Escape: Understanding the Divergent Immune Response in Breast Cancer Subtypes. Cancer Discovery. 13(1). 23–40. 133 indexed citations
9.
Ghosh-Choudhary, Shohini, Neil Carleton, Mehdi Nouraie, Corrine R. Kliment, & Richard A. Steinman. (2022). Predoctoral MD-PhD grants as indicators of future NIH funding success. JCI Insight. 7(6). 5 indexed citations
10.
Carleton, Neil, Azadeh Nasrazadani, Sushil Beriwal, et al.. (2022). Personalising therapy for early-stage oestrogen receptor-positive breast cancer in older women. The Lancet Healthy Longevity. 3(1). e54–e66. 12 indexed citations
11.
Carleton, Neil & Priscilla F. McAuliffe. (2022). Are the chronological age cutoffs used in clinical oncology guidelines biologically meaningful?. Nature Reviews Clinical Oncology. 19(12). 745–746. 4 indexed citations
12.
Syed, Aslam, et al.. (2021). Association Between Portal Vein Thrombosis and Pouchitis in Patients with Ulcerative Colitis. Digestive Diseases and Sciences. 67(4). 1303–1310. 6 indexed citations
13.
Ghosh-Choudhary, Shohini, Neil Carleton, JoAnne L. Flynn, & Corrine R. Kliment. (2021). Strategies for Achieving Gender Equity and Work–Life Integration in Physician–Scientist Training. Academic Medicine. 97(4). 492–496. 6 indexed citations
14.
Carleton, Neil, Jian Zou, Yusi Fang, et al.. (2021). Outcomes After Sentinel Lymph Node Biopsy and Radiotherapy in Older Women With Early-Stage, Estrogen Receptor–Positive Breast Cancer. JAMA Network Open. 4(4). e216322–e216322. 23 indexed citations
15.
Chen, Fangyuan, Kai Ding, Nolan Priedigkeit, et al.. (2020). Single-Cell Transcriptomic Heterogeneity in Invasive Ductal and Lobular Breast Cancer Cells. Cancer Research. 81(2). 268–281. 28 indexed citations
16.
Kochhar, Gursimran, Neil Carleton, & Shyam Thakkar. (2020). Assessing perspectives on artificial intelligence applications to gastroenterology. Gastrointestinal Endoscopy. 93(4). 971–975.e2. 9 indexed citations
18.
Syed, Aslam, Neil Carleton, Zachary D. Horne, et al.. (2019). Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. Journal of Gastrointestinal Cancer. 51(3). 836–843. 7 indexed citations
19.
Ukita, Rei, Kan Wu, Xiaojie Lin, et al.. (2019). Zwitterionic poly-carboxybetaine coating reduces artificial lung thrombosis in sheep and rabbits. Acta Biomaterialia. 92. 71–81. 61 indexed citations
20.
Gorbounov, Mikhail, Neil Carleton, Lingling Xian, et al.. (2019). High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer. Breast Cancer Research and Treatment. 179(1). 25–35. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026